Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Acta Pharmaceutica Sinica. B
|
September 6, 2021
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Shenghua Gao, Tianguang Huang, Letian Song, et al.
Acta Pharmaceutica Sinica. B
|
January 19, 2024
Letian Song, Shenghua Gao, Bing Ye, et al.
European Journal of Medicinal Chemistry
|
May 31, 2022
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features
Shenghua Gao, Yusen Cheng, Shu Song, et al.
Acta Pharmaceutica Sinica. B
|
July 10, 2023
Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
Shenghua Gao, Letian Song, Yusen Cheng, et al.
Journal of Medicinal Chemistry
|
November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Molecules (Basel, Switzerland)
|
January 8, 2023
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
Shenghua Gao, Letian Song, Hongtao Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 25, 2024
Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 M<sup>pro</sup> Inhibitors With Robust Potency and Drug-like Profile
Mianling Yang, Myoung Kyu Lee, Shenghua Gao, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
Shenghua Gao, Letian Song, Tobias Claff, et al.
Journal of Medicinal Chemistry
|
September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity
Shenghua Gao, Katharina Sylvester, Letian Song, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Acta Pharmaceutica Sinica. B
|
September 6, 2021
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Shenghua Gao, Tianguang Huang, Letian Song, et al.
Acta Pharmaceutica Sinica. B
|
January 19, 2024
Letian Song, Shenghua Gao, Bing Ye, et al.
European Journal of Medicinal Chemistry
|
May 31, 2022
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features
Shenghua Gao, Yusen Cheng, Shu Song, et al.
Acta Pharmaceutica Sinica. B
|
July 10, 2023
Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
Shenghua Gao, Letian Song, Yusen Cheng, et al.
Journal of Medicinal Chemistry
|
November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Molecules (Basel, Switzerland)
|
January 8, 2023
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
Shenghua Gao, Letian Song, Hongtao Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 25, 2024
Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 M<sup>pro</sup> Inhibitors With Robust Potency and Drug-like Profile
Mianling Yang, Myoung Kyu Lee, Shenghua Gao, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
Shenghua Gao, Letian Song, Tobias Claff, et al.
Journal of Medicinal Chemistry
|
September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity
Shenghua Gao, Katharina Sylvester, Letian Song, et al.
Page
of 2